Fri, February 21, 2020

Douglas Tsao Maintained (TXMD) at Strong Buy with Decreased Target to $300 on, Feb 21st, 2020

Douglas Tsao of HC Wainwright & Co., Maintained "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Decreased Target from $350 to $300 on, Feb 21st, 2020.

Douglas, nor any peers, have made any analyst calls on TXMD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30